Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL826690 | 0.98 | SHBG (0.36) | SHBGCA12CA1CA2MMP2 | |
| SCHEMBL3020048 | 0.95 | — | — | |
| SCHEMBL456219 | 0.90 | — | — | |
| SCHEMBL4672205 | 0.81 | — | — | |
| SCHEMBL29032098 | 0.79 | — | — | |
| SCHEMBL2961100 | 0.79 | CPN1 (0.33) | — | |
| SCHEMBL21218791 | 0.79 | — | — | |
| SCHEMBL17748236 | 0.79 | — | — | |
| SCHEMBL2848595 | 0.77 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL2839695 | 0.75 | EPHX1 (0.34) | SHBGEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115704995-A | Curable composition, cured film and application thereof, method for producing cured film, and polymer | JSR株式会社 | 2023-02-17 | — | — | CN | disclosed |
| CN-115433591-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer and method for producing same | JSR株式会社 | 2022-12-06 | — | — | CN | disclosed |
| CN-115197719-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, and method for producing same | JSR株式会社 | 2022-10-18 | — | — | CN | disclosed |
| EP-1719794-B1 | NOVEL POLYMERS AND USES THEREOF | MITSUI CHEMICALS INC (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-7977429-B2 | Polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20080124552-A1 | Particle With Rough Surface For Plating Or Vapor Deposition | NISSHINBO INDUSTRIES, INC. (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20070154431-A1 | Novel polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2007-07-05 | — | — | US | disclosed |
| EP-1719794-A1 | NOVEL POLYMERS AND USES THEREOF | Mitsui Takeda Chemicals, Inc. (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1517881-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | Syngenta Participations AG (CH) | 2005-03-30 | — | — | EP | disclosed |
| US-6812235-B2 | 2-ACYLAMINO- BETA -ALANINE DERIVATIVES AND A PHARMACEUTICALLY ACCEPTABLE SALT, USEFUL AS FIBRINOGEN RECEPTOR ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-02 | — | — | US | disclosed |
| WO-2004002943-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-01-08 | — | — | WO | disclosed |
| US-20030018193-A1 | Beta-alanine derivatives and their use as receptor anatgonists | ASTELLAS PHARMA INC. (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1255748-A1 | BETA-ALANINE DERIVATIVES AND THEIR USE AS RECEPTOR ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-13 | — | — | EP | disclosed |
| WO-2001060813-A1 | BETA-ALANINE DERIVATIVES AND THEIR USE AS RECEPTOR ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-23 | — | — | WO | disclosed |
| US-5821277-A | Thermosetting and procuring compositions for color filters and method for making the same | NIPPON OIL CO., LTD. (JP) | 1998-10-13 | — | — | US | disclosed |
| US-5811475-A | REACTING A CARBON WITH A POLYMER HAVING A REACTIVE GROUP AND A HYDROLYZABLE TERT-ALKYL ACRYLIC ESTER; PRINTING INKS; DIELECTRICS; HIGH ELECTRICAL RESISTANCE | NIPPON OIL CO., LTD. (JP) | 1998-09-22 | — | — | US | disclosed |
| EP-0753548-A2 | Method for producing carbonaceous material | NIPPON OIL COMPANY, LIMITED (JP) | 1997-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154431-A1 | Novel polymers and uses thereof | RAD54L, VCL, TYR | SHBG 4347/4885CA12 4307/4885CA1 4826/4885 |
| US-20030018193-A1 | Beta-alanine derivatives and their use as receptor anatgonists | ARRB1, ADRB1, GLRB | SHBG 174/4885CA12 937/4885CA1 662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.